Detailed analysis of pro-apoptotic signaling and metabolic adaptation triggered by a N-heterocyclic carbene-gold(I) complex

被引:47
作者
Holenya, Pavlo [1 ]
Can, Suzan [1 ]
Rubbiani, Riccardo [2 ]
Alborzinia, Hamed [1 ]
Juenger, Anja [1 ]
Cheng, Xinlai [1 ]
Ott, Ingo [2 ]
Woelfl, Stefan [1 ]
机构
[1] Ruperto Carola Univ Heidelberg, Inst Pharm & Mol Biotechnol, Dept Biol, D-69120 Heidelberg, Germany
[2] Tech Univ Carolo Wilhelmina Braunschweig, Inst Med & Pharmaceut Chem, D-38106 Braunschweig, Germany
关键词
THIOREDOXIN REDUCTASE INHIBITORS; CELL-CYCLE ARREST; CARBENE COMPLEXES; REACTIVE OXYGEN; MAMMALIAN THIOREDOXIN; MOLECULAR-MECHANISMS; GOLD(III) COMPLEXES; REGULATORY TARGET; GOLD COMPOUNDS; CANCER-CELLS;
D O I
10.1039/c4mt00075g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Due to their broad spectrum of biological activity and antiproliferative effect on different human cancer cell lines, gold compounds have been in the focus of drug research for many years. Gold(I)-N-heterocyclic carbene complexes are of particular interest, because of their stability, ease of derivatization and clear cytotoxicity in cancer cells. To obtain a more detailed view of the molecular mechanisms underlying their cellular activity, we used a novel gold(I)-N-heterocyclic carbene complex, [triphenylphosphane-(1,3-diethyl-5- methoxy-benzylimidazol-2-ylidene)]gold(I) iodide and investigated changes in cellular signaling pathways using quantitative signal transduction protein microarray analysis. We also analyzed changes in cell metabolism in a time-dependent manner by on-line metabolic measurements and used isolated mitochondria to elucidate the direct effects on this cell organelle. We found strong cytotoxic effects in cancer cells, accompanied by an immediate and irreversible loss of mitochondrial respiration as well as by a crucial imbalance of the intracellular redox state, resulting in apoptotic cell death. ELISA microarray analysis of signal transduction pathways revealed a time-dependent up-regulation of pro-apoptotic signaling proteins, e.g. p38 and JNK, whereas pro-survival signals that are directly linked to the thioredoxin system were down-regulated, which pinpoints to thioredoxin reductase as a central target of the compound. Further results suggest that DNA is an indirect target of the compound. Based on our findings, we outline a signaling model for the molecular mechanism underlying the antiproliferative activity of the gold(I)-N-heterocyclic carbene complex investigated, which provides a good general model for the known pattern of cell death induced by this class of substances.
引用
收藏
页码:1591 / 1601
页数:11
相关论文
共 62 条
[11]   ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair [J].
Cosentino, Claudia ;
Grieco, Domenico ;
Costanzo, Vincenzo .
EMBO JOURNAL, 2011, 30 (03) :546-555
[12]   CREB is a regulatory target for the protein kinase Akt/PKB [J].
Du, KY ;
Montminy, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :32377-32379
[13]   Mitochondrial reactive oxygen species in cell death signaling [J].
Fleury, C ;
Mignotte, B ;
Vayssière, JL .
BIOCHIMIE, 2002, 84 (2-3) :131-141
[14]   Gold(III) compounds as anticancer drugs [J].
Gabbiani, Chiara ;
Casini, Angela ;
Messori, Luigi .
GOLD BULLETIN, 2007, 40 (01) :73-81
[15]   Organometallic Anticancer Compounds [J].
Gasser, Gilles ;
Ott, Ingo ;
Metzler-Nolte, Nils .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) :3-25
[16]   A categorization of metal anticancer compounds based on their mode of action [J].
Gianferrara, Teresa ;
Bratsos, Ioannis ;
Alessio, Enzo .
DALTON TRANSACTIONS, 2009, (37) :7588-7598
[17]   Human placenta thioredoxin reductase - Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds [J].
Gromer, S ;
Arscott, LD ;
Williams, CH ;
Schirmer, RH ;
Becker, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) :20096-20101
[18]   CREB Is a Novel Nuclear Target of PTEN Phosphatase [J].
Gu, Tingting ;
Zhang, Zhong ;
Wang, Jianli ;
Guo, Junyi ;
Shen, Wen Hong ;
Yin, Yuxin .
CANCER RESEARCH, 2011, 71 (08) :2821-2825
[19]   Challenges and Opportunities in the Development of Organometallic Anticancer Drugs [J].
Hartinger, Christian G. ;
Metzler-Nolte, Nils ;
Dyson, Paul J. .
ORGANOMETALLICS, 2012, 31 (16) :5677-5685
[20]   Mitochondria-targeted chemotherapeutics:: The rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols [J].
Hickey, James L. ;
Ruhayel, Rasha A. ;
Barnard, Peter J. ;
Baker, Murray V. ;
Berners-Price, Susan J. ;
Filipovska, Aleksandra .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (38) :12570-+